Top 5 Indian Stocks to Buy: Cartrade Tech, Cipla, Vijay Diagnostic Centre, Fortis Healthcare, Dabur India

Indian stock markets have been witnessing volatility in recent times, with the Nifty and Sensex indices experiencing sharp fluctuations. Amidst this uncertainty, it’s essential for investors to stay informed about the latest stock market trends and analyst recommendations.

In this article, we will explore five Indian stocks that have received buy recommendations from analysts at IDBI Cap, Kushbohra.com, and JM Financial.

Cartrade Tech Ltd.

Brijesh Ail, Head Technical and Derivatives, Retail Research at IDBI Cap, suggests buying Cartrade Tech. The target price is Rs 2,200, with a stop loss at Rs 2,018. This implies an upside of 6.49%.

According to Bloomberg data, five out of the eight analysts tracking the company have a ‘buy’ rating on the stock, one recommends a ‘hold’ and two suggest a ‘sell’. The 12-month analysts’ consensus target price on the stock is Rs 2,002, implying a downside of 3.1%.

Cipla Ltd.

Brijesh Ail, Head Technical and Derivatives, Retail Research at IDBI Cap, recommends buying Cipla. The target price is Rs 1,630, with a stop loss at Rs 1558. This implies an upside of 3.82%.

According to Bloomberg data, twenty-seven out of the 40 analysts tracking the company have a ‘buy’ rating on the stock, seven recommend a ‘hold’ and four suggest a ‘sell’. The 12-month analysts’ consensus target price on the stock is Rs 1,700, implying a upside of 8.2%.

Vijay Diagnostic Centre Ltd.

IDBI Capital calls for buying Vijay Diagnostic Centre. The target price is Rs 1,190, with a stop loss at Rs 1128. This implies an upside of 4.39%.

According to Bloomberg data, eight out of the 12 analysts tracking the company have a ‘buy’ rating on the stock, two recommend a ‘hold’ and two suggest a ‘sell’. The 12-month analysts’ consensus target price on the stock is Rs 1,130, implying a downside of 1%.

Fortis Healthcare Ltd.

Kush Bohra, Founder, Kushbohra.com, gives a buy call for Fortis Healthcare. The target price is Rs 886, with a stop loss at Rs 825. This implies an upside of 4.73%.

According to Bloomberg data, fifteen out of the 16 analysts tracking the company have a ‘buy’ rating on the stock and one suggest a ‘sell’. The 12-month analysts’ consensus target price on the stock is Rs 824.8, implying a downside of 2.5%.

Dabur India Ltd.

Akshay P Bhagwat, Senior VP, JM Financial, recommends buying Dabur India. The target price is Rs 545, with a stop loss at Rs 514. This implies an upside of 4.41%.

According to Bloomberg data, fifteen out of the 42 analysts tracking the company have a ‘buy’ rating on the stock, 19 recommend a ‘hold’ and eight suggest a ‘sell’. The 12-month analysts’ consensus target price on the stock is Rs 520, implying a downside of 0.3%.

Conclusion

In conclusion, these five Indian stocks have received buy recommendations from analysts at IDBI Cap, Kushbohra.com, and JM Financial. Before investing in any stock, it’s essential to conduct thorough research and consider various factors such as the company’s financial performance, industry trends, and market conditions.

It’s also important to note that past performance is not a guarantee of future results, and investors should always consult with a financial advisor before making any investment decisions.